Intervention not reported
Time to PVR ≤ 50 mL (days) · women with stage Ia2 to IIa cervical cancer
The intervention showed no clear difference in time to PVR ≤ 50 mL (days) (low certainty).
1 finding from 1 review
Intervention not reported
PVR one month after operation (mL) · women with stage Ia2 to IIa cervical cancer
The intervention showed no clear difference in PVR one month after operation (mL) (low certainty).
1 finding from 1 review
Intervention not reported
Perioperative complications (excluding bladder dysfunction) · women with stage Ia2 to IIa cervical cancer
The intervention showed no clear difference in perioperative complications (excluding bladder dysfunction) (low certainty).
1 finding from 1 review
Intervention not reported
Disease‐free survival (median · women with stage Ia2 to IIa cervical cancer
It is very uncertain whether the intervention changes disease‐free survival (median (very low certainty).
1 finding from 1 review
Intervention not reported
Quality of life · women with stage Ia2 to IIa cervical cancer
1 finding from 1 review
Intervention not reported
PTB (< 37 w) · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) (very low certainty).
1 finding from 1 review
Intervention not reported
LBW (< 2500 g) ‐ Treatment versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes LBW (< 2500 g) ‐ Treatment versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
NICU Admission ‐ Treatment versus No Treatment · women with known obstetric outcomes
The intervention may leads to higher NICU Admission ‐ Treatment versus No Treatment (low certainty).
1 finding from 1 review
Intervention not reported
Perinatal Mortality ‐ Treatment versus No Treatment · women with known obstetric outcomes
The intervention may leads to higher perinatal Mortality ‐ Treatment versus No Treatment (low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 32 to 34 w) · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 32 to 34 w) (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 28 to 30 w) · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 28 to 30 w) (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37 w) ‐ Repeat cones versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) ‐ Repeat cones versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
pPROM (<3 7 w) · women with known obstetric outcomes
It is very uncertain whether the intervention changes pPROM (<3 7 w) (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37 w) ‐ Depth ≤ 10 mm to 12 mm versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) ‐ Depth ≤ 10 mm to 12 mm versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥10 mm to 12 mm versus No Treatment · women with known obstetric outcomes
The intervention may leads to higher PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥10 mm to 12 mm versus No… (low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37w) ‐ PTB (<37w) ‐ Depth ≥15 to 17mm versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37w) ‐ PTB (<37w) ‐ Depth ≥15 to 17mm versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥ 20 mm versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥ 20 mm versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
Overall 5‐year survival1 · women with stage I/II epithelial ovarian cancer
1 finding from 1 review
no estimate extracted
1008 participants
High
Intervention not reported
Progression‐free 5‐year survival2 · women with stage I/II epithelial ovarian cancer
1 finding from 1 review
no estimate extracted
1170 participants
High
Intervention not reported
Overall 10‐year3 survival · women with stage I/II epithelial ovarian cancer
1 finding from 1 review
no estimate extracted
925 participants
High